Belvedere Trading’s Trillium Therapeutics Inc. TRIL Stock Holding History

Belvedere Trading’s Portfolio TRIL Stock Details TRIL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-16,487	Closed	-$289K	–	733
2021 Q3	$289K	Buy	+16,487	New	+$193K	0.01%	191

Other funds holding TRIL

Optiver Holding Amsterdam, Netherlands $289B AUM 33.63% 1-Year Est. Return

Belvedere Trading's TRIL Position: Q4 2021 in Review

Belvedere Trading sold out of Trillium Therapeutics Inc. (TRIL) in Q4 2021, closing a stake of 16,487 shares — an estimated $289K sold.

Belvedere Trading first reported a position in TRIL in Q3 2021 and held it in 1 quarter. The position peaked at $289K in Q3 2021. 2 funds tracked by Wall St. Rank hold TRIL as of Q4 2021.

Belvedere Trading reported no remaining Trillium Therapeutics Inc. position as of Q4 2021 after selling out during the quarter.
Belvedere Trading sold 16,487 Trillium Therapeutics Inc. shares in Q4 2021, an estimated $289K.
Belvedere Trading first reported a position in Trillium Therapeutics Inc. in Q3 2021 and held it in 1 quarter.
Belvedere Trading's Trillium Therapeutics Inc. position peaked at $289K in Q3 2021.
2 funds tracked by Wall St. Rank held Trillium Therapeutics Inc. as of Q4 2021.

Based on Belvedere Trading's 13F filing for Q4 2021, filed 25 Jan 2022.